Willem-Jan Krebber

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Matthew M. Gubin, Xiuli Zhang, Heiko Schuster et al. · Nature · 2014 · 2K citations · Full text

Life Sciences, Immunology, Oncology +10

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

Daniel K. Wells, Marit M. van Buuren, Kristen K. Dang et al. · Cell · 2020 · 536 citations · Full text

Life Sciences, Immunology, Oncology +16

Vaccine-Induced Effector-Memory CD8+ T Cell Responses Predict Therapeutic Efficacy against Tumors

Suzanne van Duikeren, Marieke F. Fransen, Anke Redeker et al. · The Journal of Immunology · 2012 · 93 citations

Medicine, Immunology, Oncology +17

Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses

Victoria A. Brentville, Rachael L. Metheringham, Ian Daniels et al. · Journal for ImmunoTherapy of Cancer · 2020 · 53 citations · Full text

Medicine, Immunology, Oncology +17

Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions

Frank M. Speetjens, Marij J.P. Welters, Marije Slingerland et al. · Journal for ImmunoTherapy of Cancer · 2022 · 37 citations · Full text

Medicine, Immunology, Oncology +17